Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

31.38 +0.15 (+0.48%)

Official Closing Price Updated: 7:00 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

48 49 Next >

Ready For A Rebound? Here Are 10 Oversold Stocks To Watch ↗

November 17, 2025

Via Benzinga

Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today

November 17, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 4.9% in the afternoon session after news of increased competition in the weight-loss drug market overshadowed the company’s own positive...

Via StockStory

What's Going On With Hims & Hers Health Shares Monday? ↗

November 17, 2025

Shares of Hims & Hers are trading marginally lower Monday morning, as competitive news overshadows bullish announcements from the company.

Via Benzinga

Hims & Hers Announces New $250 Million Share Repurchase Program – Retail Sees A Steady Trading Range For The Stock ↗

November 17, 2025

The latest buyback program follows a $100 million share buyback program in July 2024, which has now been completed.

Via Stocktwits

Eli Lilly, Novo Nordisk Or A Dark Horse: Which Obesity-Drug Stock Are Retail Traders Most Bullish On Over Next 5 Years? ↗

November 06, 2025

Via Stocktwits

Hims & Hers Health, Inc. Announces $250 Million Share Repurchase Program Authorization

November 17, 2025

From Hims & Hers

Via Business Wire

Hims & Hers Names Deb Autor as Chief Policy Officer to Lead Global Policy and Regulatory Strategy

November 17, 2025

From Hims & Hers

Via Business Wire

Hims & Hers Introduces Labs With Annual Plans For Comprehensive Testing ↗

November 14, 2025

Hims & Hers launches Labs, offering annual biomarker testing plans with doctor-developed guidance and expanded diagnostics planned across key health categories.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 14, 2025

Via Benzinga

1 Healthcare Stock to Consider Right Now and 2 Facing Headwinds

November 13, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and...

Via StockStory

Topics Stocks

Hims & Hers Stock Logs 3-Day Losing Streak As Truist Calls Out Klarna GLP-1 Changes — Retail Sees Fresh Buy Zone ↗

November 13, 2025

Truist pointed to updated GLP-1 intake features, including Klarna financing, shorter shipping intervals and new semaglutide microdosing options.

Via Stocktwits

Looking For A Squeeze? Here Are The Top 10 Most Shorted Stocks ↗

November 13, 2025

Lucid, Avis, Hims & Hers Health and Upstart are some of the most heavily shorted stocks right now. Here's a look at the top ten.

Via Benzinga

Hims & Hers Introduces Labs, a Holistic, In-Depth Testing Experience That Puts Customers in Control of Their Health and Wellness Journeys

November 13, 2025

From Hims & Hers

Via Business Wire

2 Strong Healthcare Stock Picks for Growth Investors ↗

November 13, 2025

If you're a growth-oriented stock buyer, there are plenty of options in the healthcare space.

Via The Motley Fool

2 Quality Healthcare Stocks That Could Build a Strong Foundation for Beginner Investors ↗

November 13, 2025

Healthcare stocks have plenty to offer new investors.

Via The Motley Fool

Huge Opportunity to Buy These 4 Stocks ↗

November 12, 2025

All four of these stocks have big upside.

Via The Motley Fool

Healthcare Technology Stocks Q3 Teardown: Hims & Hers Health (NYSE:HIMS) Vs The Rest

November 11, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology stocks fared in Q3, starting with Hims...

Via StockStory

Options Corner: Hims & Hers Health's Downturn Presents A Compelling Opportunity For Quants ↗

November 11, 2025

Although Hims & Hers Health has tanked in the past month, the quantitative profile suggests a contrarian trade is brewing for HIMS stock.

Via Benzinga

Hims & Hers Health’s Q3 Earnings Call: Our Top 5 Analyst Questions

November 10, 2025

Hims & Hers Health’s third quarter results prompted a positive market reaction as the company delivered strong revenue growth driven by surging demand for personalized care, new specialty launches, and...

Via StockStory

Topics Earnings

Hims & Hers Revenue Continues to Surge. Is It Time to Buy the Stock? ↗

November 09, 2025

The company continues to have a strong growth outlook ahead.

Via The Motley Fool

The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things. ↗

November 07, 2025

The feast that saw obesity-tied stocks skyrocket in 2024 is over. Investors' appetite for weight-loss drugs has waned.

Via Investor's Business Daily

Topics Government

Can Hims & Hers Keep Its GLP-1 Edge After Trump Forces Lilly And Novo To Slash Prices? Wall Street Isn’t Convinced ↗

November 06, 2025

Citi calls Trump’s GLP-1 pricing deal “less bad than feared,” while Needham warns it could erode Hims’ cost advantage.

Via Stocktwits

Topics Government World Trade

1 Growth Stock to Stash and 2 We Ignore

November 05, 2025

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.

Via StockStory

Why Are Hims & Hers Health (HIMS) Shares Soaring Today

November 05, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 6.9% in the morning session after the company reported third-quarter 2025 results that showed strong revenue growth, even as its...

Via StockStory

Why Hims & Hers Stock May Be a Buy After Mixed Q3 Results ↗

November 05, 2025

Via MarketBeat

HIMS CEO Says 'A Little Bit of Craziness' Is The Secret To Building A Global Health Platform ↗

November 04, 2025

Hims & Hers Health (HIMS) CEO Andrew Dudum, sees potential for emotional and medical transformation and plans for global expansion.

Via Benzinga

HIMS Q3 Deep Dive: Personalized Offerings and Strategic Expansion Shape Telehealth Growth

November 04, 2025

Telehealth company Hims & Hers Health (NYSE:HIMS) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 49.2% year on year to $599 million. On the other hand, next...

Via StockStory

Hims & Hers Health Stock Jumps After-Hours As Q3 Growth, Novo Nordisk Talks Fuel Bullish Retail Bets ↗

November 03, 2025

Revenue rose 49% year-over-year to nearly $600 million, while net income reached $15.8 million and adjusted EBITDA climbed 53% to $78.4 million.

Via Stocktwits

Topics Earnings

Palantir, Kimberly-Clark, Hims & Hers, Navitas And Cipher Mining: Why These 5 Stocks Are On Investors' Radars Today ↗

November 03, 2025

PLTR, KMB, HIMS, NVTS, CIFR were among the stocks seen trending among investors on Monday, Nov. 3, 2025.

Via Benzinga

Hims Hers (HIMS) Q3 2025 Earnings Call Transcript ↗

November 03, 2025

Hims Hers (HIMS) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

< Previous 1 2 3 4 5 6 7 8 9

...

48 49 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

All News about Hims & Hers Health, Inc. Class A Common Stock

Starting at $3.75/week.

Subscribe Today